NCT06065592 2023-10-06
CAT_PB
Lebanese University
Phase 1 Unknown
Clinical Trials
7 trialsNCT05178628 2022-03-29
imPaCT-PRO
Institute of Molecular Medicine and Biomedical Research
Phase 3 Unknown
NCT05067153 2021-10-05
TOP-RCT
University of Aarhus
Phase 4 Unknown
NCT04246073 2020-07-31
Prospective Evaluation of Efficacy and Safety of Fondaparinux in Surgical Cancer Patients, Risk Factors for Thromboembolism
Hellenic Society of Surgical Oncology
Unknown
NCT04301362 2020-03-12
FIIT_Score
Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E.
Unknown
NCT00519805 2011-08-08
Dalteparin in Preventing Blood Clots in Patients With Lung Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00400504 2006-11-17
Hypercoagulability and Thromboembolic Risk in Patients With Malignant Disease, Evaluated by Thrombelastograph (TEG®)
Rigshospitalet, Denmark
Unknown